Shikonin alleviates bone cancer pain through suppression of spinal IGF2-associated p38 MAPK signaling
zhenghang Ma, Jin Jia, Dashan Lu…·Yao Ming
This study shows that intrathecal Shikonin reduces bone cancer pain in rats by suppressing spinal IGF2-associated p38 MAPK signaling, improving pain-related behaviors and reducing inflammation.